A Transformational Case Study – AbbVie Pharmaceutical

Sickness and health issues have been in front of us for months now.  Working styles have changed over the course of the year as people have gone to WFH, staff rotations, and cutting of central business district office footprints.  We’ve heard a lot from various industries through CEO Insights, but in the August meeting, we would like to introduce the pharma perspective to the group.

AbbVie is a leading global pharmaceutical company. Spun off from Abbott in 2013, AbbVie`s flagship product, Humira, is the largest selling pharmaceutical product ever. AbbVie Japan has nearly 1500 employees and is the largest affiliate outside of the US, with annual sales of over $1B.

James Feliciano has been the President of AbbVie Japan since 2016 and has led the organization through a 5-Year transformational project called “The 5-Year Focus”. Focusing on “Driving Growth” and “Employee Engagement”, the organization has risen from #27 in 2016 for the Great Place to Work Employee Engagement Survey to #11 in 2020. During that same time, the company has moved to a “Work Anytime, Anywhere” culture supported with a new, activity-based flexible office. Employee retention remains above 95%, while the company`s Japan industry revenue ranking has jumped from #35 in 2016 to #20 in 2019.

James will share his experience of leading the 5-Year Focus in Japan, insights that he has learned along the way around driving employee engagement and considerations for the post-Covid world.

We look forward to seeing you at the August CI luncheon.  Be sure to RSVP below.  Space is limited.